TCI Wealth Advisors, Inc. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 303 filers reported holding BLUEBIRD BIO INC in Q4 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2022$4,000
-33.3%
844
+164.6%
0.00%0.0%
Q3 2021$6,000
+50.0%
319
+175.0%
0.00%0.0%
Q2 2021$4,000116
+1188.9%
0.00%
Q1 2020$0
-100.0%
90.0%0.00%
Q4 2019$1,0000.0%90.0%0.00%
Q3 2019$1,0000.0%90.0%0.00%
Q2 2019$1,000
-50.0%
9
-18.2%
0.00%
-100.0%
Q1 2019$2,000
+100.0%
110.0%0.00%
Q4 2018$1,000
-50.0%
11
-8.3%
0.00%
-100.0%
Q3 2018$2,0000.0%12
-20.0%
0.00%0.0%
Q2 2018$2,0000.0%15
+36.4%
0.00%0.0%
Q1 2018$2,0000.0%110.0%0.00%0.0%
Q4 2017$2,0000.0%110.0%0.00%0.0%
Q3 2017$2,000
+100.0%
110.0%0.00%0.0%
Q2 2017$1,0000.0%110.0%0.00%0.0%
Q1 2017$1,0000.0%110.0%0.00%0.0%
Q4 2016$1,000
-87.5%
11
-90.1%
0.00%
-75.0%
Q3 2016$8,000
+60.0%
1110.0%0.00%
+33.3%
Q2 2016$5,000111
+909.1%
0.00%
Q1 2016$0
-100.0%
11
+37.5%
0.00%
-100.0%
Q4 2015$1,00080.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2017
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,964,000$59,215,0001.36%
Birchview Capital, LP 75,500$2,276,0001.35%
Camber Capital Management LP 1,000,000$30,150,0001.04%
Sessa Capital IM, L.P. 875,000$26,381,0001.02%
Bain Capital Life Sciences Investors, LLC 538,179$16,226,0000.92%
Tarsadia Capital, LLC 100,000$3,015,0000.81%
Bullseye Asset Management LLC 67,872$2,046,0000.76%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,304,246$39,323,0000.58%
MANGROVE PARTNERS IM, LLC 175,178$5,282,0000.53%
Parametrica Management Ltd 37,712$1,080,0000.52%
View complete list of BLUEBIRD BIO INC shareholders